Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Liposomal iron in moderate chronic kidney disease
Enrique Montagud-Marrahi; Pilar Arrizabalaga; Rosa Abellana; Esteban Poch;
Nefrologia (English Version). 2020;40:446-52
Oxidative stress and inflammation on metabolic abnormalities and renal involvement in prediabetic subjects across Europe
Sebastián Mas-Fontao; Esther Civantos; Nisa Boukichou-Abdelkader; Manuel Soto-Catalan; Marta Romeo-Colas; Arantxa Marco; Carmen Gomez-Guerrero; Juan Antonio Moreno; Jaakko Tuomilehto; Rafael Gabriel; Jesús Egido;
Nefrologia (English Version). 2025;45:238-48
Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis
Juan Francisco Navarro-González; Alberto Ortiz; Ana Cebrián Cuenca; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:857-67